Please login to the form below
symptoms
This page shows the latest symptoms news and features for those working in and with pharma, biotech and healthcare.
Rigel and Ultragenyx claim approvals for rare drugs
The symptoms, which also include impaired bone growth, dental problems and severe pain, are linked to low blood phosphate levels.
Latest news
-
Amgen and Novartis migraine drug hits the mark again
Amgen and Novartis’much-anticipated new migraine drug Aimovig has generated positive data in another late-stage trial, halving migraine days in 30% of patients with continued symptoms despite multiple earlier
-
Alexion adds to pipeline rebuild with $855m Wilson buy
in turn - severe liver damage as well as neurological symptoms such as impaired movement, speech, swallowing, and psychiatric disorders.
-
AbbVie’s upadacitinib aces phase III trial
A 20% or more improvement in symptoms (ACR20) was seen in 71% of the upadacitinib group, versus 63% for Humira and 36% for placebo, which just achieved statistical significance, but ... The results were achieved in patients with moderate-to-severe RA who
-
AbbVie’s uterine fibroids drug aces second phase III trial
In many cases they cause no symptoms, but around a quarter of women experience pain, abnormal bleeding and other symptoms, with some finding they have difficulty getting pregnant.
-
Arthritis patient group launches interactive video initiative
Getting to a diagnosis can therefore often be challenging as people don’t recognise the symptoms as a medical emergency.
More from news
Approximately 2 fully matching, plus 1,003 partially matching documents found.
Latest Intelligence
-
The challenges of making genomics a reality for patients
The symptom most commonly associated with the condition is progressive lung damage, but cystic fibrosis affects a multitude of organs in the body meaning half of patients don’t make it
-
A new era of smart pharma
It must be used alongside diligent medical care so that patients with paranoid symptoms feel reassured rather than have their condition reinforced.
-
Health on instalment
Gene therapies target the underlying disease itself, not symptoms, and often fix the problem permanently.
-
Speech therapy
The first of these studies looked at ‘Woebot’, a Facebook Messenger bot delivering text-based cognitive behavioural therapy, which successfully reduced self-reported symptoms of depression in its users.
-
The challenges of making genomics a reality for patients today, not tomorrow
The symptom most commonly associated with the condition is progressive lung damage, but cystic fibrosis affects a multitude of organs in the body meaning half of patients don’t make it
More from intelligence
Approximately 0 fully matching, plus 68 partially matching documents found.
Latest appointments
-
Srdjan Stankovic joins Acadia Pharmaceuticals
Acadia is at the forefront in developing groundbreaking medicines to treat debilitating symptoms associated with these diseases.
-
Bayer's Kirstyn Nicholas joins Spirit Healthcare
Nicholas has previously specialised in the provision of medical devices designed to help manage screening, symptoms and treatment.
-
Ex-Bayer R&D chief joins Gemmus Pharma board
San Francisco-based Gemmus was founded in 2007 and is developing a drug that decreases the severity of flu symptoms by modulating the release of pro-inflammatory cytokines.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Living with Crohn's disease: a patient perspective
Symptoms are unpredictable and affect everyday living, significantly impacting on quality of life. ... Diagnosis can take up to three years due to delayed presentation of symptoms and misdiagnosis.
-
Could ketamine be the next big thing in depression?
Depression is a leading cause of disability worldwide and with more than 1 in 10 suffering from symptoms, it is likely to affect many of us in some way over our ... Although antidepressants reliably increase neurotransmitter levels in the brains
-
The difference between market intelligence and design intelligence
Market intelligence effectively identifies the symptoms that indicate there may be an underlying problem driving customers’ reported behaviour and resulting analytics.
-
Innovating with what you have: better healthcare with existing technology
Patients (usually elderly) were presenting themselves in A&E with symptoms too minor to warrant a hospital stay, or too late, with clinicians having missed an opportunity for earlier, possibly
-
Artificial Intelligence: the new healthcare algorithm
First, they might pose a query to the system, describing symptoms and other related factors (e.g.
More from PMHub
Approximately 0 fully matching, plus 72 partially matching documents found.
Featured jobs
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Account Manager – Med Comms – London
-
Salary TBC
- Group Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Project Manager, Medical Communications, London
-
Excellent Salary
- Senior Account Director, Healthcare Brand Communications, London
-
Excellent Package
-
Senior Medical Writer
-
Great salary and bebefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Senior Programme Executive
-
Salary TBC
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Project Manager, Medical Communications, Oxford
-
Excellent Salary
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Editor – Medical Education Agency – Bucks
-
Salary TBC
-
Senior Medical Writer
-
Great salary and benefits
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Scientific Director
-
Great salary and bebefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
Subscribe to our email news alerts
- BenevolentAI raises $115m to fund drug development
- Shire rebuffs Takeda bids, as Allergan bows out
- Abeona Therapeutics names CEO
- Zelluna Immunotherapy appoints chief technology officer
- Spirit Health Group offers new market access consultancy service
- Why heading online for scientific meetings can yield greater HCP engagement
PMHub
Bedrock Healthcare Communications
Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...
Latest intelligence
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Quick links
Infographics
